Efficacy and Safety of Udenafil for the Treatment of Pulmonary Arterial Hypertension: a Placebo-controlled, Double-blind, Phase IIb Clinical Trial

Arterial Hypertension ◽

Efficacy And Safety ◽

Double Blind ◽

Double-Blind, Placebo-Controlled Clinical Trial With a Rho-Kinase Inhibitor in Pulmonary Arterial Hypertension

Circulation Journal ◽

10.1253/circj.cj-13-0443 ◽

2013 ◽

Vol 77 (10) ◽

pp. 2619-2625 ◽

Cited By ~ 96

Author(s):

Yoshihiro Fukumoto ◽

Norikazu Yamada ◽

Hiromi Matsubara ◽

Minori Mizoguchi ◽

Kazuaki Uchino ◽

...

Keyword(s):

Clinical Trial ◽

Arterial Hypertension ◽

Kinase Inhibitor ◽

Rho Kinase ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Rho Kinase Inhibitor ◽

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/rccm.201908-1640oc ◽

2020 ◽

Vol 201 (6) ◽

pp. 707-717 ◽

Cited By ~ 15

Author(s):

R. James White ◽

Carlos Jerjes-Sanchez ◽

Gisela Martina Bohns Meyer ◽

Tomas Pulido ◽

Pablo Sepulveda ◽

...

Keyword(s):

Clinical Trial ◽

Combination Therapy ◽

Arterial Hypertension ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and safety of sildenafil citrate in Pulmonary Arterial Hypertension (PAH): Results of a multinational, randomized, double-blind, placebo-controlled trial

American Journal of Hypertension ◽

10.1016/j.amjhyper.2005.03.260 ◽

2005 ◽

Vol 18 (5) ◽

pp. A93-A93

Author(s):

L RUBIN ◽

G BURGESS ◽

T PARPIA ◽

D BADESCH

Keyword(s):

Arterial Hypertension ◽

Controlled Trial ◽

Sildenafil Citrate ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

PULSAR: A phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-011) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH)

10.1183/13993003.congress-2019.pa4750 ◽

2019 ◽

Author(s):

David Badesch ◽

Simon Gibbs ◽

Mardi Gomberg-Maitland ◽

Marc Humbert ◽

Vallerie Mclaughlin ◽

...

Keyword(s):

Arterial Hypertension ◽

Standard Of Care ◽

Controlled Study ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

IMATINIB MESYLATE TREATMENT FOR SEVERE PULMONARY ARTERIAL HYPERTENSION: A PROPOSED PHASE III 24-WEEK DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL

CHEST Journal ◽

10.1378/chest.136.4_meetingabstracts.64s ◽

2009 ◽

Vol 136 (4) ◽

pp. 64S ◽

Cited By ~ 1

Author(s):

Robyn J. Barst ◽

Ardeschir Ghofrani ◽

Nick Morrell ◽

Marius Hoeper ◽

Horst Olschewski ◽

...

Keyword(s):

Clinical Trial ◽

Severe Pulmonary Arterial Hypertension

Arterial Hypertension ◽

Randomized Clinical Trial ◽

Imatinib Mesylate ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Pulmonary Arterial ◽

Advance Outcomes - A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in Subjects with Pulmonary Arterial Hypertension

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3819 ◽

2020 ◽

Author(s):

R. Channick ◽

V.F. Tapson ◽

M. Humbert ◽

C. Deng ◽

M. Escudero ◽

...

Keyword(s):

Arterial Hypertension ◽

Treatment Outcomes ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Improve Treatment ◽

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717967956.793467610 ◽

2012 ◽

Author(s):

Robin Steinhorn

Keyword(s):

Arterial Hypertension ◽

Sildenafil Citrate ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve ◽

Dose Ranging ◽

Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(21)00032-1 ◽

2021 ◽

Author(s):

Stephan Rosenkranz ◽

Jeremy Feldman ◽

Vallerie V McLaughlin ◽

Franz Rischard ◽

Tobias J Lange ◽

...

Keyword(s):

Arterial Hypertension ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Trial ◽

Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses

European Heart Journal ◽

10.1093/eurheartj/ehq152 ◽

2010 ◽

Vol 31 (17) ◽

pp. 2080-2086 ◽

Cited By ~ 93

Author(s):

N. Galie ◽

M. Palazzini ◽

A. Manes

Keyword(s):

Clinical Trial ◽

Arterial Hypertension ◽

Pulmonary Arterial ◽

Meta Analyses

Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants

Annals of the American Thoracic Society ◽

10.1513/annalsats.202110-1139oc ◽

2021 ◽

Author(s):

Jeff Min ◽

Dina H Appleby ◽

Robyn L McClelland ◽

Jasleen Minhas ◽

John H Holmes ◽

...

Keyword(s):

Clinical Trial ◽

Arterial Hypertension ◽

Regional Trends ◽

Pulmonary Arterial ◽

Trial Participants